33 related articles for article (PubMed ID: 1983322)
1. Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.
Cremonini F; Ziogas DC; Chang HY; Kokkotou E; Kelley JM; Conboy L; Kaptchuk TJ; Lembo AJ
Aliment Pharmacol Ther; 2010 Jul; 32(1):29-42. PubMed ID: 20353496
[TBL] [Abstract][Full Text] [Related]
2. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.
Wang WH; Huang JQ; Zheng GF; Xia HH; Wong WM; Lam SK; Wong BC
World J Gastroenterol; 2005 Jul; 11(26):4067-77. PubMed ID: 15996033
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.
Sharma N; Donnellan C; Preston C; Delaney B; Duckett G; Moayyedi P
Gut; 2004 May; 53 Suppl 4(Suppl 4):iv58-65. PubMed ID: 15082617
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis.
Wesdorp IC; Dekker W; Festen HP
Dig Dis Sci; 1993 Dec; 38(12):2287-93. PubMed ID: 8261835
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent heart rate reducing effect of nizatidine, a histamine H2-receptor antagonist.
Hinrichsen H; Halabi A; Fuhrmann G; Kirch W
Br J Clin Pharmacol; 1993 May; 35(5):461-6. PubMed ID: 8099802
[TBL] [Abstract][Full Text] [Related]
6. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.
Bell NJ; Hunt RH
Gut; 1992 Jan; 33(1):118-24. PubMed ID: 1346769
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of gastro-oesophageal reflux disease.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
[TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Medical treatments in the short term management of reflux oesophagitis.
Moayyedi P; Santana J; Khan M; Preston C; Donnellan C
Cochrane Database Syst Rev; 2011 Feb; (2):CD003244. PubMed ID: 21328259
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis.
Quik RF; Cooper MJ; Gleeson M; Hentschel E; Schuetze K; Kingston RD; Mitchell M
Aliment Pharmacol Ther; 1990 Apr; 4(2):201-11. PubMed ID: 1983322
[TBL] [Abstract][Full Text] [Related]
10. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
[TBL] [Abstract][Full Text] [Related]
11. Treatment of erosive reflux oesophagitis: a double-blind multicentre trial with nizatidine 300 mg b.i.d. versus placebo.
Dobrilla G; Chilovi F; Tafner G; Vantini I; Bernardi A; Gentilini R; Fedrizzi F; Manfrini R; Steiner H; Mon M
Ital J Gastroenterol; 1992; 24(6):338-41. PubMed ID: 1515660
[TBL] [Abstract][Full Text] [Related]
12. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
[TBL] [Abstract][Full Text] [Related]
13. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial.
Naccaratto R; Cremer M; Dammann HG; Keohane PP; Mulder H; Sarles H; Simon B
Scand J Gastroenterol Suppl; 1987; 136():71-8. PubMed ID: 2892258
[TBL] [Abstract][Full Text] [Related]
14. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
